Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Bin Yan Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6696-7471; OpenAlex author ID A5017090255. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 2 papers · 2022: none · 2023: none · 2024: 2 papers

Papers 7

  1. CXCL5 Promotes the Malignant Phenotype of Pancreatic Cancer and Is Associated With Immune Infiltration. Last author DOI 10.1177/11795549241271691↗
  2. Leveraging CAR macrophages targeting c-Met for precision immunotherapy in pancreatic cancer: insights from single-cell multi-omics. Last author DOI 10.1186/s10020-024-00996-4↗
  3. The expression and clinical prognostic value of protein phosphatase 1 catalytic subunit beta in pancreatic cancer. Co-author DOI 10.1080/21655979.2021.1934243↗
  4. The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis. Last author DOI 10.1186/s12957-021-02420-1↗
  5. CXCL5 expression in tumor tissues is associated with poor prognosis in patients with pancreatic cancer. Co-author DOI 10.3892/ol.2020.12120↗
  6. Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. Co-author DOI 10.6004/jnccn.2020.7587↗
  7. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2174/1566524018666180308115705↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yiyu Shen · 3 shared papers, 2020–2024 · strength 0.54
  2. Zhengxiang Zhong · 4 shared papers, 2017–2021 · strength 0.50
  3. Fei Chen · 2 shared papers, 2021–2024 · strength 0.42
  4. Lingyu Hu · 2 shared papers, 2021 · strength 0.31
  5. Lingyu Hu · 1 shared paper, 2024 · strength 0.28
  6. Zhengwei Song · 1 shared paper, 2024 · strength 0.28
  7. Xiaoguang Wang · 2 shared papers, 2020–2021 · strength 0.27
  8. Tao Wang · 1 shared paper, 2024 · strength 0.24
  9. Lizheng Shi · 1 shared paper, 2020 · strength 0.24
  10. Haokai Xu · 1 shared paper, 2021 · strength 0.14
  11. Wei Chen · 1 shared paper, 2021 · strength 0.14
  12. Jing Wang · 1 shared paper, 2020 · strength 0.13
  13. Z S Li · 1 shared paper, 2017 · strength 0.07
  14. Jun Gao · 1 shared paper, 2017 · strength 0.07
  15. J. Zhang · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.